Fair enough the study is ongoing, but 50% have completed and those preliminary results are outstanding. There was no statistical change in the children that didn't have the treatment ...
Market is waiting for 100% of the results to rerate this ...
I don't see how the remaining 50% of children to be tested could skew far from these results, so to me, this is a massive result and as much of a hint as you can ask for
NTI Price at posting:
26.0¢ Sentiment: Buy Disclosure: Held
